Synergistic Anti-Tumor Effect of Chidamide and Linperlisib on Natural Killer/T-Cell Lymphoma by Inhibiting PI3K/AKT/mTOR Pathway.

Jiang W, Shi Z, Li Z, Feng X, Zhang X, Zhang M, Han L

Open source

DOI
10.1002/hon.70256
Published
2026 Sep
Container
Hematological oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hon.70256,
  title = {Synergistic Anti-Tumor Effect of Chidamide and Linperlisib on Natural Killer/T-Cell Lymphoma by Inhibiting PI3K/AKT/mTOR Pathway.},
  author = {Jiang W and Shi Z and Li Z and Feng X and Zhang X and Zhang M and Han L},
  year = {2026},
  journal = {Hematological oncology},
  doi = {10.1002/hon.70256},
  url = {https://doi.org/10.1002/hon.70256}
}

RIS

TY  - JOUR
TI  - Synergistic Anti-Tumor Effect of Chidamide and Linperlisib on Natural Killer/T-Cell Lymphoma by Inhibiting PI3K/AKT/mTOR Pathway.
AU  - Jiang W
AU  - Shi Z
AU  - Li Z
AU  - Feng X
AU  - Zhang X
AU  - Zhang M
AU  - Han L
PY  - 2026
JO  - Hematological oncology
DO  - 10.1002/hon.70256
UR  - https://doi.org/10.1002/hon.70256
ER  - 

APA

W, J., Z, S., Z, L., X, F., X, Z., M, Z., & L, H. (2026). Synergistic Anti-Tumor Effect of Chidamide and Linperlisib on Natural Killer/T-Cell Lymphoma by Inhibiting PI3K/AKT/mTOR Pathway.. Hematological oncology. https://doi.org/10.1002/hon.70256

Source records